Funder: Alliance for Cancer Gene Therapy

Due Dates: June 1, 2024 (LOI) | September 15, 2024 (Full application, by invitation)

Funding Amounts: Up to $500,000 over 2–3 years (including max 10% indirect costs)

Summary: Supports research advancing cell and gene therapy solutions for pancreatic cancer, targeting its microenvironment and immune challenges.

Key Information: LOI required; research must be conducted at academic centers in the US or Canada.